Tempest Therapeutics's total assets for Q1 2026 were $10.75M, a decrease of -36.52% from the previous quarter. TPST total liabilities were $9.93M for the fiscal quarter, a -3.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.